Gw Pharma ADR (GWPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,019 | 15,927 | 29,684 | -50,064 | N/A |
| Depreciation Amortization | 9,240 | 7,096 | 4,808 | 2,417 | N/A |
| Income taxes - deferred | -9,698 | N/A | N/A | N/A | N/A |
| Accounts receivable | -44,623 | -37,691 | -27,924 | -14,998 | N/A |
| Other Working Capital | -60,653 | -61,682 | -17,399 | -22,674 | N/A |
| Other Operating Activity | -8,716 | -31,172 | -79,030 | 26,937 | 0 |
| Operating Cash Flow | $-123,469 | $-107,522 | $-89,861 | $-58,382 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -42,488 | -31,098 | -23,532 | -12,286 | N/A |
| Other Investing Activity | 104,117 | 104,117 | 104,117 | 0 | 0 |
| Investing Cash Flow | $61,629 | $73,019 | $80,585 | $-12,286 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -317 | N/A | N/A | N/A |
| Debt Repayment | -543 | -404 | -273 | -317 | N/A |
| Common Stock Issued | 2,878 | 2,878 | 2,878 | 773 | N/A |
| Other Financing Activity | -389 | 0 | -250 | 0 | 0 |
| Financing Cash Flow | $1,946 | $2,157 | $2,355 | $456 | $N/A |
| Exchange Rate Effect | 5,330 | -4,469 | -893 | 384 | N/A |
| Beginning Cash Position | 591,497 | 591,497 | 591,497 | 591,497 | N/A |
| End Cash Position | 536,933 | 554,682 | 583,683 | 521,669 | N/A |
| Net Cash Flow | $-54,564 | $-36,815 | $-7,814 | $-69,828 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -123,469 | -107,522 | -89,861 | -58,382 | N/A |
| Capital Expenditure | -42,488 | -31,098 | -23,532 | -12,286 | N/A |
| Free Cash Flow | -165,957 | -138,620 | -113,393 | -70,668 | 0 |